Procter, Gamble

Procter & Gamble Faces Headwinds as Consumer Spending Cools

24.01.2026 - 07:21:04

Procter & Gamble US7427181091

Procter & Gamble's latest quarterly results present a mixed picture for investors. While the consumer goods giant managed to edge past earnings expectations, it is simultaneously grappling with softening demand in core business segments and has trimmed its full-year profit forecast. The central challenge is clear: inflation-weary shoppers, particularly in the critical U.S. market, are pulling back, making it evident that price increases alone can no longer drive growth. All eyes are now on the company's ability to deliver on its promised recovery in the latter half of the fiscal year.

The company's new Chief Executive, Shailesh Jejurikar, who took the helm at the beginning of the month, steps into a difficult operating environment. In his first remarks to investors, he struck a cautiously optimistic tone, expressing confidence in the company's plans to achieve better results in the second half of the fiscal year. He pointed to upcoming product innovations as a key lever for growth.

Echoing this sentiment, Chief Financial Officer Andre Schulten explicitly labeled the second quarter as "the weakest of the fiscal year." He indicated that targeted actions in the U.S. market—focusing on pricing, promotions, and assortment—are expected to gain traction in the coming months. The management's message is that the current quarter may represent a low point, but they must now prove they can engineer a turnaround.

Earnings: Surface Stability Meets Underlying Pressure

For the quarter ending December 31, 2025, P&G reported revenue of $22.2 billion, a modest 1% increase year-over-year. A more telling metric, however, is organic sales, which strip out the effects of foreign exchange and acquisitions. This figure showed no growth, stagnating at 0%.

The earnings story reveals a similar dichotomy between headline and detail:
* Core Earnings Per Share (EPS) remained flat at $1.88, slightly above analyst estimates of $1.86.
* In contrast, diluted GAAP EPS declined by 5% to $1.78, weighed down by higher restructuring costs.
* Overall shipment volume fell by 1% across the corporation, while adjusted free cash flow productivity remained solid at 88%.

Market reaction has been measured so far. Shares closed Friday at $150.26, positioning the stock approximately 10% below its 52-week high but still significantly above its low over the past twelve months.

Segment Performance: Volume Declines Signal Consumer Shift

Beneath the stable top-line numbers, a clear trend is emerging: P&G is selling fewer units in several key divisions. Three of its five product categories reported declining volumes, suggesting households are either cutting back or trading down to more affordable alternatives.

Beauty Stands Out as a Bright Spot
The Beauty segment provided a positive contrast, with volume growing 3% and organic sales rising 4%. Hair care and skin & personal care led the way, posting mid-single-digit percentage gains and demonstrating that P&G can still command pricing power and demand in select categories.

Challenges in Baby, Feminine & Family Care
The most pronounced weakness was in the Baby, Feminine & Family Care unit, where organic sales dropped 4% and volume fell 5%. Established household brands like Bounty, Charmin, and Puffs faced notable pressure. Part of this decline is attributed to a difficult comparison with the prior-year period, when retailers built up inventories ahead of potential port strikes.

Should investors sell immediately? Or is it worth buying Procter & Gamble?

Grooming Segment Feels the Pinch
The Grooming business, home to the Gillette and Venus razor brands, also showed cracks. Volume declined 2%. Although innovation allowed for higher prices in North America and Europe, weaker unit sales resulted in overall organic revenue for the segment staying flat compared to the previous year.

Profitability and Guidance: Tariffs Take a Toll

Pressure on profitability was evident. The reported gross margin contracted by 120 basis points. While the company achieved 160 basis points of productivity gains and captured an additional 50 basis points from pricing, these were offset by negative impacts from product mix, reinvestments, and tariffs:
* Unfavorable mix: –120 basis points
* Product and brand reinvestment: –60 basis points
* Tariff costs: –60 basis points

For the full fiscal year, P&G anticipates after-tax tariff costs of approximately $400 million—a substantial sum even for a company of its scale.

The company revised its full-year GAAP earnings outlook downward, now expecting diluted EPS growth in a range of 1% to 6%, compared to a prior forecast of 3% to 9%. Management attributed this change solely to higher restructuring costs, not an operational deterioration.

Crucially, the core (adjusted) financial guidance for the year remains unchanged:
* Organic sales growth: 0% to 4%
* Core EPS: Flat to up 4% versus the $6.83 per share earned in fiscal 2025 (equating to $6.83 to $7.09 per share)
* Adjusted free cash flow productivity: 85% to 90%
* Dividend payments: Approximately $10 billion
* Share repurchases: Approximately $5 billion

This reaffirmation of its core targets and substantial shareholder return program is a key signal to investors focused on stability and income.

Geographic Split: International Markets Provide Support

Regionally, performance was divided. The U.S. market struggled with consumer restraint, but international regions bolstered the overall result. Latin America delivered 8% organic sales growth, while the Europe Enterprise region grew by 6%. In total, five of P&G's seven geographic regions posted gains in organic sales, highlighting the importance of its global diversification in offsetting domestic softness.

The Path Forward

In summary, Procter & Gamble's quarter encapsulates the current challenges facing the consumer staples sector: resilient core earnings but palpable pressure on volumes and margins, especially in the U.S. and in discretionary categories like home care and grooming. The reduced GAAP outlook acknowledges higher restructuring costs, while the maintained operational forecast underscores management's confidence.

The true test will come in the second half of the fiscal year. Success will depend on whether new products, targeted U.S. market actions, and continued international strength can put volume and earnings back on a clearer growth trajectory. If so, investor focus is likely to shift from short-term headwinds to the anticipated recovery.

Ad

Procter & Gamble Stock: Buy or Sell?! New Procter & Gamble Analysis from January 24 delivers the answer:

The latest Procter & Gamble figures speak for themselves: Urgent action needed for Procter & Gamble investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from January 24.

Procter & Gamble: Buy or sell? Read more here...

@ boerse-global.de | US7427181091 PROCTER